|
JP2021004263A
|
|
Pharmaceutical composition comprising propionic acid-based nonsteroidal antiinflammatory agent
|
|
JP2020203874A
|
|
Oral pharmaceutical composition containing loxoprofen or salt thereof, and japanese valerian
|
|
JP2020196710A
|
|
Combined medication for prevention and/or treatment of dysmenorrhea
|
|
JP2020158501A
|
|
Skin external preparation containing loxoprofen and solubilizer
|
|
JP2020158502A
|
|
Skin external preparation containing loxoprofen
|
|
JP2020169151A
|
|
Oral pharmaceutical composition containing loxoprofen or salt thereof and taurine
|
|
JP2020169152A
|
|
Oral pharmaceutical composition containing loxoprofen or salt thereof and moutan bark
|
|
JP2020147514A
|
|
Composition containing bile acid and herbal medicine
|
|
JP2019142856A
|
|
Loxoprofen-containing skin external preparation
|
|
JP2019127488A
|
|
Pharmaceutical compositions comprising olopatadine
|
|
JP2018188429A
|
|
External preparation for skin containing loxoprofen
|
|
JP2018076312A
|
|
Pharmaceutical composition containing acetaminophen, isopropylantipyrine and ginger-derived components
|
|
JP2019052110A
|
|
Oral composition
|
|
JP2018043982A
|
|
Cationic bactericidal agent, unmodified silica, and oral composition containing betaine-based surfactant
|
|
JP2019011306A
|
|
Pharmaceutical composition
|
|
JP2018012695A
|
|
Oral pharmaceutical composition containing loxoprofen or salt thereof and vitamin b12
|
|
JP2018012693A
|
|
Oral pharmaceutical composition containing loxoprofen or salt thereof and vitamin e
|
|
JP2017200909A
|
|
External preparation for skin containing loxoprofen
|
|
JP2018177330A
|
|
Refill container and application container using the same
|
|
JP2018177331A
|
|
Exterior container for refill container and application container using the same
|
